Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is 25.22x as of the fiscal period ended Sunday, September 30, 2012.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
25.22x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+491.66%
vs the sector median at left
Utah Medical Products, Inc.
Market Cap
$235.08M
Interest Coverage Ratio
25.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.66M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$235.97M
Interest Coverage Ratio
N/A
TTM Avg
28.01x
3Y Avg
25.48x
5Y Avg
25.48x
Market Cap
$236.82M
Interest Coverage Ratio
-133.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$232.72M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.37M
Interest Coverage Ratio
-8.56x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.01M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Utah Medical Products, Inc. (UTMD) | $235.08M | 25.22x | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 0.97x | 0.97x | 0.97x | 0.97x |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | N/A | 28.01x | 25.48x | 25.48x |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -133.11x | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $232.72M | -1280.37x | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | -8.56x | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | -1.08x | 0.39x | 0.39x | 0.20x |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | N/A | N/A | N/A |
Interest Coverage
25.2x
Debt/Equity
0.00
Current Ratio
48.62
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2012-09-30 | 25.22x |